About the Authors
- Tea Soon Park
-
Affiliations Institute for Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America, Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States of America
- Jeffrey S. Huo
-
Affiliations Institute for Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America, Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States of America
- Ann Peters
-
Affiliations Institute for Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America, Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States of America
- C. Conover Talbot Jr.
-
Affiliation Institute for Basic Biomedical Sciences at Johns Hopkins, Baltimore, Maryland, United States of America
- Karan Verma
-
Affiliations Institute for Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America, Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States of America
- Ludovic Zimmerlin
-
Affiliations Institute for Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America, Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States of America
- Ian M. Kaplan
-
Affiliations Institute for Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America, Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States of America
- Elias T. Zambidis
-
* E-mail: ezambid1@jhmi.edu
Affiliations Institute for Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America, Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States of America
Competing Interests
The authors have the following conflicts: Under a licensing agreement between Life Technologies Corporation and the Johns Hopkins University, Dr. Zambidis is entitled to a share of royalty received by the University on sales of human induced pluripotent stem cell lines. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its Conflict of Interest policies. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: ETZ TSP JSH AP. Performed the experiments: TSP JSH CCT AP KV LZ IMK ETZ. Analyzed the data: TSP JSH CCT AP LZ KV IMK ETZ. Wrote the paper: ETZ. Provided administrative support: ETZ.